Oscar Diagnostic Services Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.37 M
as on 14-12-2024
- Company Age 32 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 3.50 M
as on 14-12-2024
- Revenue -22.68%
(FY 2021)
- Profit 3.08%
(FY 2021)
- Ebitda -5.72%
(FY 2021)
- Net Worth 11.44%
(FY 2021)
- Total Assets -9.88%
(FY 2021)
About Oscar Diagnostic Services
The Corporate was formerly known as Vega Systems Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.37 M.
The company currently has active open charges totaling ₹3.50 M.
Poonam Kumar and Alok Kumar serve as directors at the Company.
- CIN/LLPIN
U33110DL1992PTC048922
- Company No.
048922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 May 1992
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Oscar Diagnostic Services Private Limited offer?
Oscar Diagnostic Services Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Oscar Diagnostic Services?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Kumar  | Director | 01-Jan-2010 | Current |
| Alok Kumar | Director | 01-Jan-2010 | Current |
Financial Performance of Oscar Diagnostic Services.
Oscar Diagnostic Services Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 22.68% decrease. The company also saw a slight improvement in profitability, with a 3.08% increase in profit. The company's net worth Soared by an impressive increase of 11.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oscar Diagnostic Services?
In 2021, Oscar Diagnostic Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Geneact Biotech Private LimitedActive 12 years 25 daysPoonam Kumar and Alok Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ing Vysya Bank Limited Creation Date: 26 Feb 2013 | ₹3.50 M | Open |
How Many Employees Work at Oscar Diagnostic Services?
Unlock and access historical data on people associated with Oscar Diagnostic Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oscar Diagnostic Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oscar Diagnostic Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
